A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
Clicks: 139
ID: 214317
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
136 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor that can be used to treat a variety of RNA virus infections, is expected tâ¦
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (24 words).
Try re-searching for a better abstract.
| Reference Key |
2020europeana12
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | |
| Journal | European journal of medicinal chemistry |
| Year | 2020 |
| DOI |
10.1016/j.ejmech.2020.112527
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.